<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00643656</url>
  </required_header>
  <id_info>
    <org_study_id>EudraCT : 2006-004203-19</org_study_id>
    <nct_id>NCT00643656</nct_id>
  </id_info>
  <brief_title>Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion</brief_title>
  <official_title>Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide Santé International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Air Liquide Santé International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the
      realization of liver biopsy in order to relax him and to reduce his pain during this painful
      medical treatment. This single investigator centre and national clinical trial is done
      blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of
      them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in
      this clinical protocol.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain measurement by using Visual Analog Scale (VAS)</measure>
    <time_frame>At the end of the liver biospy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient's acceptance and doctor's satisfaction</measure>
    <time_frame>At the end of the liver biopsy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">94</enrollment>
  <condition>Liver Biopsy</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mixture of 50% nitrous oxide and 50% oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Mixture of 50% oxygen and 50% nitrogen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Kalinox 170 bar</intervention_name>
    <description>Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mix of 50% oxygen and 50% nitrogen</intervention_name>
    <description>Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient requiring a liver biopsy of focal lesion

          -  Age upper than 18 years

          -  OMS : 0 to 3

          -  patient consent form signed

        Exclusion Criteria:

          -  patient unable to use Visual Analog Scale (VAS)

          -  OMS upper than 3

          -  coagulation disorder

          -  contraindication linked to the experimental product

          -  patient already included in another clinical trial uncompatible with this trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beaujon hospital</name>
      <address>
        <city>Clichy</city>
        <zip>92118</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2008</study_first_submitted>
  <study_first_submitted_qc>March 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2008</study_first_posted>
  <last_update_submitted>January 9, 2009</last_update_submitted>
  <last_update_submitted_qc>January 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2009</last_update_posted>
  <responsible_party>
    <name_title>Peter ONODY, MD</name_title>
    <organization>Air Liquide Santé International</organization>
  </responsible_party>
  <keyword>Liver biopsy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

